Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 4/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.33 |
| ▸ | HTT | P42858 | 4/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.32 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24378003 | 0.79 | L3MBTL1 (0.36) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL22828906 | 0.79 | L3MBTL1 (0.36) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL22828321 | 0.71 | GAA (0.44) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL22828743 | 0.64 | GAA (0.37) | MAPTGAAALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL24378018 | 0.64 | ALDH1A1 (0.37) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1354532 | 0.63 | GAA (0.43) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1354531 | 0.63 | GAA (0.43) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1355461 | 0.62 | GAA (0.39) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1355462 | 0.62 | GAA (0.39) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13810647 | 0.60 | ALDH1A1 (0.43) | MAPTGAAL3MBTL1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002393-A1 | CDK KINASE INHIBITOR | BEIJING BENICALL BIOTECH CO LTD (CN) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002393-A1 | CDK KINASE INHIBITOR | CDK6, CDK4, CDK9 | MAPT 2216/4885GAA 1585/4885L3MBTL1 3486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.